MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes

Punashi Dutta1, Edward Haller2, Arielle Sharp3

  • 1Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, 33620, USA. punashidutta@mail.usf.edu.

BMC Cancer
|January 23, 2016
PubMed
Abstract

Insights

MicroRNA 494 (MIR494) reduces renal cancer cell survival by promoting lipid droplet formation in a process dependent on LC3B. This study also observed mitochondrial alterations in MIR494-expressing cells.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • MicroRNAs (miRNAs) regulate cell survival in cancers.
  • Lipid droplet formation is linked to apoptotic cell death.
  • The role of MIR494 in renal cancer and its association with lipid droplets remain unclear.

Purpose of the Study:

  • To investigate if MIR494 reduces survival in renal cancer cells.
  • To determine if MIR494 expression affects lipid droplet formation.
  • To explore the mechanism of MIR494-induced cell death and lipid droplet changes.

Main Methods:

  • 769-P renal carcinoma cells were transfected with MIR494 mimic.
  • Cell viability, apoptosis, lipid droplet accumulation, and cholesterol levels were assessed.
  • Transmission electron microscopy, western blotting, and immunofluorescence were used to analyze cellular and mitochondrial changes.

Main Results:

  • MIR494 expression decreased cell viability and increased apoptosis markers.
  • MIR494 significantly increased lipid droplet and multilamellar body formation.
  • MIR494 altered mitochondrial organization and was dependent on LC3B for lipid droplet formation.

Conclusions:

  • MIR494 acts as a tumor suppressor in renal cancer cells.
  • MIR494-induced cell death involves increased lipid droplet formation via an LC3B-dependent pathway.
  • Mitochondrial alterations are associated with MIR494 expression and lipid droplet accumulation.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K